| Aktie | Ticker | Breite | GCS | 2026/Q1 | 2025/Q4 | 2025/Q3 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | ||||
| 997.928.316 $ | +244.268.567 $ | +34,4 % | 9 | 568.824.590 $ | +94.130.432 $ | +40,2 % | 6 | 1.206.632.036 $ | +395.961.829 $ | +87,5 % | 10 | ||||
| Merus N.V. | → 0 | 331.878.750 $ | +146.463.750 $ | +79,0 % | 1 | ||||||||||
| Relay Therapeutics, Inc. | RLAY | → 0 | Schwach | 169.150.000 $ | +25.330.000 $ | +17,6 % | 1 | 143.820.000 $ | +55.080.000 $ | +62,1 % | 1 | 88.740.000 $ | +42.549.000 $ | +92,1 % | 1 |
| Alkermes plc. | ALKS | → 0 | Stark | 148.512.000 $ | +49.183.000 $ | +49,5 % | 1 | 99.329.000 $ | +6.426.380 $ | +6,9 % | 1 | 92.902.620 $ | +22.808.120 $ | +32,5 % | 1 |
| Enliven Therapeutics, Inc. | ELVN | → 0 | Neutral | 128.380.000 $ | +56.110.741 $ | +77,6 % | 1 | 96.061.800 $ | +1.924.051 $ | +2,0 % | 1 | ||||
| Nuvalent, Inc. | NUVL | → 0 | 85.402.320 $ | +30.077.820 $ | +54,4 % | 1 | 121.072.000 $ | +16.159.500 $ | +15,4 % | 1 | |||||
| Cogent Biosciences, Inc. | COGT | → 0 | Neutral | 111.159.389 $ | +33.127.455 $ | +42,5 % | 1 | 78.031.934 $ | -26.078.066 $ | -25,0 % | 1 | 104.110.000 $ | +87.515.842 $ | +527,4 % | 1 |
| Xenon Pharmaceuticals Inc. | XENE | → 0 | Neutral | 80.676.000 $ | -27.729.000 $ | -25,6 % | 1 | 108.405.000 $ | +13.722.500 $ | +14,5 % | 1 | ||||
| Spyre Therapeutics, Inc. | SYRE | → 0 | Neutral | 96.460.447 $ | +18.221.541 $ | +23,3 % | 1 | 78.238.906 $ | +44.918.618 $ | +134,8 % | 1 | ||||
| Tyra Biosciences, Inc. | TYRA | → 0 | Schwach | 94.792.500 $ | +6.063.750 $ | +6,8 % | 1 | 88.728.750 $ | +41.512.500 $ | +87,9 % | 1 | ||||
| AGIOS PHARMACEUTICALS, INC. | AGIO | → 0 | Neutral | 93.858.840 $ | +16.529.340 $ | +21,4 % | 1 | ||||||||
| SOLENO THERAPEUTICS INC | SLNO | → 0 | 91.260.000 $ | +40.154.200 $ | +78,6 % | 1 | |||||||||
| Celldex Therapeutics, Inc. | CLDX | → 0 | Schwach | 85.536.660 $ | +15.871.260 $ | +22,8 % | 1 | 78.343.026 $ | +8.135.526 $ | +11,6 % | 1 | ||||
| Amylyx Pharmaceuticals, Inc. | AMLX | → 0 | Neutral | 78.535.000 $ | +10.283.000 $ | +15,1 % | 1 | ||||||||
| 997.928.316 $ | +244.268.567 $ | +34,4 % | 9 | 568.824.590 $ | +94.130.432 $ | +40,2 % | 6 | 1.206.632.036 $ | +395.961.829 $ | +87,5 % | 10 | ||||